DCNSF(DCNSF)
DCNSF
No analyst ratings available
No analyst price targets available for DCNSF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $11.24T | $11.42T | $11.58T | $11.76T | $12.11T |
| Low | $10.73T | $10.79T | $10.99T | $11.17T | $11.50T |
| High | $11.80T | $12.14T | $12.23T | $12.42T | $12.79T |
| EBITDA Avg | $151.67B | $152.90B | $154.18B | $155.61B | $157.88B |
| Low | $151.38B | $152.58B | $153.85B | $155.29B | $157.55B |
| High | $152.01B | $153.25B | $154.53B | $155.97B | $158.25B |
| EBIT Avg | $4.55B | $4.79B | $4.88B | $4.88B | $5.05B |
| Low | $4.25B | $4.48B | $4.56B | $4.56B | $4.72B |
| High | $4.88B | $5.14B | $5.24B | $5.23B | $5.42B |
| Net Income Avg | $3.41B | $3.59B | $3.66B | $3.66B | $3.79B |
| Low | $3.19B | $3.36B | $3.42B | $3.42B | $3.54B |
| High | $3.66B | $3.86B | $3.93B | $3.92B | $4.07B |
| EPS Avg | $148.77 | $156.65 | $159.62 | $159.36 | $165.17 |
| Low | $139.01 | $146.38 | $149.15 | $148.91 | $154.34 |
| High | $159.65 | $168.11 | $171.29 | $171.01 | $177.25 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $2.62T | $2.92T | $2.85T | $2.45T | $2.47T | $2.49T | $2.51T | $2.53T |
| Low | $2.62T | $2.92T | $2.85T | $2.45T | $2.47T | $2.49T | $2.51T | $2.53T |
| High | $2.62T | $2.92T | $2.85T | $2.45T | $2.47T | $2.49T | $2.51T | $2.53T |
| EBITDA Avg | $14.23B | $15.76B | $16.86B | $17.52B | $18.54B | $19.58B | $20.28B | $20.71B |
| Low | $14.23B | $15.76B | $16.86B | $17.52B | $18.54B | $19.58B | $20.28B | $20.71B |
| High | $14.23B | $15.76B | $16.86B | $17.52B | $18.54B | $19.58B | $20.28B | $20.71B |
| EBIT Avg | $1.02B | $1.26B | $1.19B | $1.00B | $1.20B | $1.45B | $1.39B | $1.08B |
| Low | $1.02B | $1.26B | $1.19B | $1.00B | $1.20B | $1.45B | $1.39B | $1.08B |
| High | $1.02B | $1.26B | $1.19B | $1.00B | $1.20B | $1.45B | $1.39B | $1.08B |
| Net Income Avg | $762M | $948M | $893M | $751M | $900M | $1.09B | $1.04B | $807M |
| Low | $762M | $948M | $893M | $751M | $900M | $1.09B | $1.04B | $807M |
| High | $762M | $948M | $893M | $751M | $900M | $1.09B | $1.04B | $807M |
| EPS Avg | $34.42 | $42.79 | $40.31 | $33.93 | $40.64 | $49.23 | $46.96 | $36.44 |
| Low | $34.42 | $42.79 | $40.31 | $33.93 | $40.64 | $49.23 | $46.96 | $36.44 |
| High | $34.42 | $42.79 | $40.31 | $33.93 | $40.64 | $49.23 | $46.96 | $36.44 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |